Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.16 - $0.31 $29,880 - $57,892
186,750 New
186,750 $28,000
Q2 2022

Aug 10, 2022

SELL
$0.24 - $1.2 $288 - $1,444
-1,204 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.94 - $2.38 $18,103 - $45,836
-19,259 Reduced 94.12%
1,204 $1,000
Q4 2021

Feb 14, 2022

BUY
$1.89 - $3.12 $38,675 - $63,844
20,463 New
20,463 $53,000
Q3 2021

Nov 15, 2021

SELL
$2.34 - $3.77 $18,727 - $30,171
-8,003 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$3.48 - $4.45 $40,997 - $52,425
-11,781 Reduced 59.55%
8,003 $29,000
Q1 2021

May 12, 2021

BUY
$3.57 - $6.2 $13,915 - $24,167
3,898 Added 24.54%
19,784 $73,000
Q4 2020

Feb 11, 2021

BUY
$4.4 - $7.32 $59,589 - $99,134
13,543 Added 578.02%
15,886 $83,000
Q3 2020

Nov 12, 2020

SELL
$4.38 - $8.35 $79,448 - $151,460
-18,139 Reduced 88.56%
2,343 $12,000
Q2 2020

Jul 31, 2020

BUY
$3.64 - $9.26 $73,822 - $187,802
20,281 Added 10090.05%
20,482 $152,000
Q1 2020

May 01, 2020

SELL
$2.54 - $9.38 $20,878 - $77,103
-8,220 Reduced 97.61%
201 $1,000
Q4 2019

Feb 14, 2020

SELL
$7.07 - $9.51 $3,761 - $5,059
-532 Reduced 5.94%
8,421 $80,000
Q3 2019

Nov 14, 2019

BUY
$7.77 - $11.26 $69,564 - $100,810
8,953 New
8,953 $70,000
Q3 2018

Nov 14, 2018

SELL
$6.57 - $8.31 $1,918 - $2,426
-292 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.93 - $8.93 $1,147 - $2,607
292 New
292 $2,000
Q1 2018

May 15, 2018

SELL
$2.88 - $6.29 $6,842 - $14,945
-2,376 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$4.22 - $5.21 $4,063 - $5,017
963 Added 68.15%
2,376 $12,000
Q3 2017

Nov 14, 2017

SELL
$3.23 - $4.93 $42,025 - $64,144
-13,011 Reduced 90.2%
1,413 $7,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,582 Added 33.04%
14,424 $106,000
Q1 2017

Nov 14, 2017

BUY
N/A
10,842
10,842 $76,000

Others Institutions Holding QTNT

# of Institutions
1
Shares Held
1.71K
Call Options Held
0
Put Options Held
0

About Quotient Ltd


  • Ticker QTNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Description
  • Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...
More about QTNT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.